HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing

The increasing prevalence of acquired and transmitted HIV-1 drug resistance is an obstacle to successful antiretroviral therapy (ART) in the low- and middle-income countries (LMICs) hardest hit by the HIV-1 pandemic. Genotypic drug resistance testing could facilitate the choice of initial ART in are...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhee, Soo-Yon, Jordan, Michael R., Raizes, Elliot, Chua, Arlene, Parkin, Neil, Kantor, Rami, Van Zyl, Gert U., Mukui, Irene, Hosseinipour, Mina C., Frenkel, Lisa M., Ndembi, Nicaise, Hamers, Raph L., Rinke de Wit, Tobias F., Wallis, Carole L., Gupta, Ravindra K., Fokam, Joseph, Zeh, Clement, Schapiro, Jonathan M., Carmona, Sergio, Katzenstein, David, Tang, Michele, Aghokeng, Avelin F., De Oliveira, Tulio, Wensing, Annemarie M. J., Gallant, Joel E., Wainberg, Mark A., Richman, Douglas D., Fitzgibbon, Joseph E., Schito, Marco, Bertagnolio, Silvia, Yang, Chunfu, Shafer, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696791/
https://www.ncbi.nlm.nih.gov/pubmed/26717411
http://dx.doi.org/10.1371/journal.pone.0145772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696791/
https://www.ncbi.nlm.nih.gov/pubmed/26717411
http://dx.doi.org/10.1371/journal.pone.0145772

Ejemplares similares